Abstract:Human chorionic gonadotropin &bgr; (hCG&bgr;) is a kind of pregnancy hormones, moreover, it is a tumor-associated antigen ectopically expressed on a variety of human non-trophoblastic tumors such as pancreatic cancer, bladder cancer and lung cancer. Therefore, hCG&bgr; is considered as an ideal target antigen. However, as a self-antigen, hCG&bgr; is tolerated by the immune system and immune response is hardly induced. 9-mer of L-arginine (Arg9), a type of cell penetrating peptide, can play an important role in the translocation process. Firstly, we designed and constructed two eukaryotic expressing plasmids including pCDNA3.1-hCG&bgr;-Arg9 (phCG&bgr;-Arg9) and pCDNA3.1-hCG&bgr; (phCG&bgr;). Secondly, B16.E5, a B16 cell line expressing hCG&bgr;, was acquired by transfected B16-F10 cells with phCG&bgr; and selected with G418. Meanwhile we constructed hCG&bgr;-Arg9 gene modified tumor cell vaccine by transient transfection of phCG&bgr;-Arg9 into B16-F10 cells with liposome. Finally, we took the prophylactic vaccination experiment in vivo to investigate the protective efficacy and the immune mechanisms. The transfectant with highest expression of hCG&bgr; was screened and named B16.E5 as a tumor model in this experiment. The results of protective experiment demonstrated 60% mice of hCG&bgr;-Arg9 group were protected from the challenge of B16.E5 cells. Moreover, survival benefit was also observed in mice vaccinated with the hCG&bgr;-Arg9 tumor vaccine (48.4 ± 4.9 days) compared with controls. Then, the experiments for immune mechanism were conducted, including T lymphocytes adoptive transfer experiment, CTL-mediated cytotoxicity analysis, hCG&bgr; antibody tests of serum after vaccination and serum transfer analysis. All of these suggested cellular immunity, rather than humoral immunity, may play the major role in the antitumor activity. We designed and constructed the tumor cell vaccine modified with hCG&bgr;-Arg9 gene and demonstrated that this vaccine can induce cellular immunity, through which the vaccine can play protective efficacy in animal experiments. Our work may contribute to designing novel generation of tumor vaccines.

Immunogenic Comparison for Two Different Recombinant Chimeric Peptides (CP12 and CP22) Containing One or Two Copies of Three Linear B Cell Epitopes from Β-Hcg Subunit

CONSTRUCTION AND IMMUNOGENICITY OF Hcg CHIMERIC PEPTIDES (CP1 and CP10) CONTAINING THREE SELF- B CELL EPITOPES AND SIX FOREIGN T CELL EPITOPES

[Expression and Purification of Three Fusion Proteins Containing a Single B-cell Epitope (beta5, Beta9 or Beta8) of Human Chorionic Gonadotropin Beta Subunit].

Ten tandem repeats of β-hCG 109–118 enhance immunogenicity and anti-tumor effects of β-hCG C-terminal peptide carried by mycobacterial heat-shock protein HSP65

Fusion of hC3d3 to hCGβ enhances responsiveness in vitro of human peripheral immunocompetent cells upon the antigen primary challenge

The Expression of HCG Epitope Fused to Hepatits B Virus Core Antigen.

The Immunogenicity of Recombinant and Dimeric Gonadotrophin-Releasing Hormone Vaccines Incorporating a T-helper Epitope and GnRH or Repeated GnRH Units

Cloning, Expression, and Purification of a Highly Immunogenic Recombinant Gonadotropin-Releasing Hormone (gnrh) Chimeric Peptide

Vaccination with the Repeat Β-Hcg C-terminal Peptide Carried by Heat Shock Protein-65 (HSP65) for Inducing Antitumor Effects

Enhancement of humoral immunity to the hCGβ protein antigen by fusing a molecular adjuvant C3d3

Construction of Eukaryotic Expression Vector of Human Chorionic Gonadotropin Beta Subunit(hcgβ) and Hcgβ Transient Expression in Hela Cell

The Study of Immunological Response to Long-Term Releaes System of Hcd Microsphere System in C_(57) Black Mouse

The Construction of Pcr-Hbc-x6-βhcg CTP37 DNA Vaccine and Its Transfection in Vitro

Preparation of the Anti-Human Chorionic Gonadotrophin Β-Subunit Monoclonal Antibodies Based on the Genetic Immunization with Recombinant Plasmid and Characterization of Its Biological Properties

A Novel Polyclonal Antibody Against Human Cytomegalovirus: General Characteristics and Potential Application in Diagnosis

Preclinical Evaluations of Peptide-Conjugate Vaccines Targeting the Antigenic Domain-2 of Glycoprotein B of Human Cytomegalovirus.

[The Immunization Effects of HBV Core Antigen and Surface Antigen Fusion Protein in Mice].

The Expression of Fusion Protein Hcgβ-C3d3 in Lactobacillus

Antitumor immunity against hCGβ induced by a tumor cell vaccine modified with a fusion gene of hCGβ and polyarginines

Construction and Characterization of an HCV-derived Multi-Epitope Peptide Antigen Containing B-cell HVR1 Mimotopes and T-cell Conserved Epitopes

C3d3 Enhances Anti-Hcgβ Response by Gene Fusion to Hcgβ in DNA Immunization in Mice of Different Strains